Global Multiple Sclerosis Therapies Report 2020-2025
08 déc. 2020 08h53 HE
|
Research and Markets
Dublin, Dec. 08, 2020 (GLOBE NEWSWIRE) -- The "Multiple Sclerosis Therapies Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-2025" report has been added to...
Neurodegenerative Disorder Therapeutics Market, 2030 - Development of Novel therapies for Neurodegenerative Disorders through Gene and Cell Therapies
22 oct. 2020 01h08 HE
|
Research and Markets
Dublin, Oct. 22, 2020 (GLOBE NEWSWIRE) -- The "Global Neurodegenerative Disorder Therapeutics Market: Focus on Product, Mechanism, Route of Administration, Indication, Country Data (14 Countries),...
New Research Demonstrate Biogen’s Continued Commitment to Improve Care of Patients with Multiple Sclerosis Across Treatment Spectrum
12 sept. 2019 05h00 HE
|
Biogen Inc.
Data highlight benefits of TYSABRI® (natalizumab) treatment in early multiple sclerosis for achieving NEDA (no evidence of disease activity) and improving disability and cognitionAn analysis of data...